Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zoran Rankovic

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
ACS Medicinal Chemistry Letters|March 18, 2022
Development of Potent and Selective Janus Kinase 2/3 Directing PG-PROTACsLisa J Alcock, Yunchao Chang, Jamie A Jarusiewicz, et al.
Molecular Cancer Therapeutics|November 1, 2022
Combination of Ribociclib with BET-Bromodomain and PI3K/mTOR Inhibitors for Medulloblastoma Treatment In Vitro and In VivoBarbara Jonchere, Justin Williams, Frederique Zindy, et al.
Nature Communications|October 2, 2020
Structural basis for substrate recognition and chemical inhibition of oncogenic MAGE ubiquitin ligasesSeung Wook Yang, Xin Huang, Wenwei Lin, et al.
ACS Medicinal Chemistry Letters|February 16, 2023
Phenyl Dihydrouracil: An Alternative Cereblon Binder for PROTAC DesignJamie A Jarusiewicz, Satoshi Yoshimura, Anand Mayasundari, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2010
Structure based evolution of a novel series of positive modulators of the AMPA receptorCraig Jamieson, John K F Maclean, Christopher I Brown, et al.
Blood|May 12, 2023
The orally bioavailable GSPT1/2 degrader SJ6986 exhibits in vivo efficacy in acute lymphoblastic leukemiaYunchao Chang, Fatemeh Keramatnia, Pankaj S Ghate, et al.
Science Translational Medicine|August 24, 2022
Preclinical evaluation of proteolytic targeting of LCK as a therapeutic approach in T cell acute lymphoblastic leukemiaJianzhong Hu, Jamie Jarusiewicz, Guoqing Du, et al.
ACS Medicinal Chemistry Letters|October 16, 2024
Structure-Activity Relationship of Potent, Selective, and Orally Bioavailable Molecular Glue Degraders of CK1αGisele Nishiguchi, Elizabeth A Caine, Kevin McGowan, et al.
Bioorganic & Medicinal Chemistry Letters|September 1, 2010
A novel series of positive modulators of the AMPA receptor: discovery and structure based hit-to-lead studiesCraig Jamieson, Stephanie Basten, Robert A Campbell, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2003
2-(Aminomethyl)-benzamide-based glycine transporter type-2 inhibitorsKoc-Kan Ho, Kenneth C Appell, John J Baldwin, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
ACS Medicinal Chemistry Letters|March 18, 2022
Development of Potent and Selective Janus Kinase 2/3 Directing PG-PROTACsLisa J Alcock, Yunchao Chang, Jamie A Jarusiewicz, et al.
Molecular Cancer Therapeutics|November 1, 2022
Combination of Ribociclib with BET-Bromodomain and PI3K/mTOR Inhibitors for Medulloblastoma Treatment In Vitro and In VivoBarbara Jonchere, Justin Williams, Frederique Zindy, et al.
Nature Communications|October 2, 2020
Structural basis for substrate recognition and chemical inhibition of oncogenic MAGE ubiquitin ligasesSeung Wook Yang, Xin Huang, Wenwei Lin, et al.
ACS Medicinal Chemistry Letters|February 16, 2023
Phenyl Dihydrouracil: An Alternative Cereblon Binder for PROTAC DesignJamie A Jarusiewicz, Satoshi Yoshimura, Anand Mayasundari, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2010
Structure based evolution of a novel series of positive modulators of the AMPA receptorCraig Jamieson, John K F Maclean, Christopher I Brown, et al.
Blood|May 12, 2023
The orally bioavailable GSPT1/2 degrader SJ6986 exhibits in vivo efficacy in acute lymphoblastic leukemiaYunchao Chang, Fatemeh Keramatnia, Pankaj S Ghate, et al.
Science Translational Medicine|August 24, 2022
Preclinical evaluation of proteolytic targeting of LCK as a therapeutic approach in T cell acute lymphoblastic leukemiaJianzhong Hu, Jamie Jarusiewicz, Guoqing Du, et al.
ACS Medicinal Chemistry Letters|October 16, 2024
Structure-Activity Relationship of Potent, Selective, and Orally Bioavailable Molecular Glue Degraders of CK1αGisele Nishiguchi, Elizabeth A Caine, Kevin McGowan, et al.
Bioorganic & Medicinal Chemistry Letters|September 1, 2010
A novel series of positive modulators of the AMPA receptor: discovery and structure based hit-to-lead studiesCraig Jamieson, Stephanie Basten, Robert A Campbell, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2003
2-(Aminomethyl)-benzamide-based glycine transporter type-2 inhibitorsKoc-Kan Ho, Kenneth C Appell, John J Baldwin, et al.
Pageof 7